SOC neoadjuvant FLOT (or FLOT-D) + simvastatin clinical trials

RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial

This study looks at adding a common cholesterol drug, simvastatin, to standard cancer treatment for stomach and gullet cancers. We want to see if it helps treatment work better and keeps cancer away longer, offering a simple way to improve care.